Lisa Richardson, M.D., M.P.H., director of the Centers for Disease Control and Prevention's (CDC) Division of Cancer Prevention and Control, discusses the CDC's role in the National Cancer Moonshot Initiative.
Lisa Richardson, M.D., M.P.H., director of the Centers for Disease Control and Prevention's (CDC) Division of Cancer Prevention and Control, discusses the CDC's role in the National Cancer Moonshot Initiative.
Now is the time when the CDC is working to double down on their current efforts, such as a their partnership with the American Cancer Society to have 80 percent colorectal cancer screening by 2018. But then they must look beyond next year, both with this particular project and with the Moonshot in general, to see how they can sustain their efforts against cancer.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More